FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.

Oncotarget · 2016 · PMC5288160 · PMID 27224915

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was also a trend towards inferior PFS in both the GCB ( P = 0.0987) and non-GCB ( P = 0.0873) DLBCL subgroups that did not reach statistical significance (Figure 3E–3F ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.